Viral vector-based gene therapy drugs are pharmaceutical products that use viral vectors to deliver therapeutic genes into target cells for the treatment of genetic disorders or diseases. These drugs typically contain modified viruses as vectors to efficiently and safely transfer genetic material into the cells of patients, aiming to correct genetic mutations or induce specific therapeutic effects.
The global Viral Vector-Based Gene Therapy Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
Key Features:
- ReportPrime's newest research report, the “Viral Vector-Based Gene Therapy Drugs Industry Forecast” looks at past sales and reviews total world Viral Vector-Based Gene Therapy Drugs sales in 2022.
- This report provides comprehensive analysis by region and market sector of projected Viral Vector-Based Gene Therapy Drugs sales for 2023 through 2029.
- Sales are broken down by region, market sector, and sub-sector.
- This report analyzes strategies of leading global companies with a focus on Viral Vector-Based Gene Therapy Drugs portfolios, market entry strategies, and geographic footprints.
Segmentation by Type:
- Retroviral Vector
- Adenovirus Vector
- Lentiviral Vector
- Others
Segmentation by Application:
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
Market by Region:
- Americas: United States, Canada, Mexico, Brazil
- APAC: China, Japan, Korea, Southeast Asia, India, Australia
- Europe: Germany, France, UK, Italy, Russia
- Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries
Company Coverage:
- GSK
- MolMed
- GILD
- JW Therapeutics
- Sibiono
- Latima
- Novartis
- Bluebird Bio
- Thermo Fisher Scientific
- Intas
- BMS
- Orchard Therapeutics
- Shanghai Sunway Biotech
- uniQure
- Spark Therapeutics
Key Questions Addressed in this Report:
Frequently Asked Questions
What is the USP of the report? expand_more
Viral Vector-Based Gene Therapy Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Viral Vector-Based Gene Therapy Drugs report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Viral Vector-Based Gene Therapy Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.